Search Within

Harry W Herr

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (75)
  2. Meeting Abstract (19)
  3. Book Section (2)
  4. Conference Paper (2)
  5. Guidelines (2)
  6. Book Whole (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Review (1)
Groups
  1. Department of Medicine (104)
  2. Genitourinary Oncology Service (104)
  3. Solid Tumor Oncology Division (104)
  4. Surgery (104)
  5. Urology (104)
  6. Survivorship Research (36)

More Groups

People
  1. Dean Bajorin (73)
  2. Howard Scher (34)
  3. Sherri Donat (34)
  4. Bernard Bochner (33)
  5. Guido Dalbagni (32)
  6. Pramod Sogani (23)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (4)
  5. 2021 (2)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Journal of Urology (16)
  3. Cancer (11)
  4. Urologic Oncology: Seminars and Original Investigations (5)
  5. European Urology (3)
  6. Seminars in Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Elsevier Science, Inc. (21)
  3. Wiley Blackwell (13)
  4. Elsevier Inc. (11)
  5. Lippincott Williams & Wilkins (4)
  6. Informa Healthcare (2)

More Publishers

Results (104)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer
    Meeting Abstract

    De Jesus Escano, M. R.; Sjoberg, D. D.; McCarter, M.; McGill, M.; Goh, A.; Donahue, T. F.; Donat, M. S.; Cha, E. K.; Herr, H. W.; Meraney, A. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
    Journal Article

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Tully, C.; Regazzi, A. M.; Pietzak, E.; Solit, D. B.; Tickoo, S.; Reuter, V.; Cha, E. K.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Neoadjuvant gemcitabine-cisplatin plus radical cystectomy-pelvic lymph node dissection for muscle-invasive bladder cancer: A 12-year experience
    Journal Article

    Iyer, G.; Tully, C. M.; Zabor, E. C.; Bochner, B. H.; Dalbagni, G.; Herr, H. W.; Donat, S. M.; Russo, P.; Ostrovnaya, I.; Regazzi, A. M.; more...
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Trends in management and outcomes among patients with urothelial carcinoma undergoing radical cystectomy from 1995 to 2015: The Memorial Sloan Kettering experience
    Journal Article

    Almassi, N.; Cha, E. K.; Vertosick, E. A.; Huang, C.; Wong, N.; Dason, S.; McPherson, V.; Dean, L.; Benfante, N.; Sjoberg, D. D.; more...
    Journal of Urology (2020)

    Fulltext@MSK | Save
  • Reply by authors
    Correspondence

    Almassi, N.; Cha, E. K.; Vertosick, E. A.; Huang, C.; Wong, N.; Dason, S.; McPherson, V.; Dean, L.; Benfante, N.; Sjoberg, D. D.; more...
    Journal of Urology (2020)

    Fulltext@MSK | Save
  • EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - An international collaborative multistakeholder effort under the auspices of the EAU-ESMO Guidelines Committees
    Guidelines

    Witjes, J. A.; Babjuk, M.; Bellmunt, J.; Maxim Bruins, H.; De Reijke, T. M.; De Santis, M.; Gillessen, S.; James, N.; Maclennan, S.; Palou, J.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - An international collaborative multi-stakeholder effort: Under the auspices of the EAU and ESMO Guidelines Committees†
    Guidelines

    Horwich, A.; Babjuk, M.; Bellmunt, J.; Bruins, H. M.; De Reijke, T. M.; De Santis, M.; Gillessen, S.; James, N.; Maclennan, S.; Palou, J.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy
    Journal Article

    Feuerstein, M. A.; Goldstein, L.; Reaves, B.; Sun, A.; Goltzman, M.; Morganstern, B. A.; Shabsigh, A.; Bajorin, D. F.; Rosenberg, J. E.; Donat, S. M.; more...
    World Journal of Urology (2019)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save